| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 522.86B | 481.44B | 440.22B | 408.20B | 417.89B |
| Gross Profit | 522.86B | 481.44B | 537.38B | 500.22B | 417.89B |
| EBITDA | 50.21B | 43.01B | 32.94B | 38.74B | 30.91B |
| Net Income | 39.33B | 32.17B | 24.59B | 29.16B | 22.36B |
Balance Sheet | |||||
| Total Assets | 860.87B | 778.24B | 703.62B | 670.35B | 682.62B |
| Cash, Cash Equivalents and Short-Term Investments | 29.31B | 8.56B | 192.42B | 10.85B | 13.31B |
| Total Debt | 79.01B | 21.73B | 9.68B | 10.06B | 9.84B |
| Total Liabilities | 572.04B | 517.62B | 469.32B | 453.09B | 476.97B |
| Stockholders Equity | 286.10B | 257.92B | 231.42B | 218.71B | 202.89B |
Cash Flow | |||||
| Free Cash Flow | 57.29B | 33.28B | 17.81B | 37.15B | 13.92B |
| Operating Cash Flow | 60.64B | 36.46B | 20.54B | 42.71B | 16.34B |
| Investing Cash Flow | -61.30B | -27.55B | -11.13B | -32.19B | -8.16B |
| Financing Cash Flow | 4.49B | -6.05B | -14.22B | -7.00B | -16.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$321.63B | 8.31 | 14.21% | 3.77% | 6.50% | 25.27% | |
70 Outperform | HK$80.43B | 2.48 | 29.19% | 1.81% | 11.51% | 250.65% | |
69 Neutral | HK$389.14B | 9.89 | 18.91% | 3.28% | 10.54% | 27.66% | |
68 Neutral | HK$339.29B | -37.16 | 15.71% | 3.05% | 9.46% | 9.49% | |
68 Neutral | HK$43.59B | 6.52 | 10.97% | 5.22% | 3.44% | 15.71% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | HK$55.22B | 4.62 | 8.96% | 3.22% | 9.10% | -7.65% |